Pyomyositis
WikiDoc Resources for Pyomyositis |
Articles |
---|
Most recent articles on Pyomyositis Most cited articles on Pyomyositis |
Media |
Powerpoint slides on Pyomyositis |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Pyomyositis at Clinical Trials.gov Clinical Trials on Pyomyositis at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Pyomyositis
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Pyomyositis Discussion groups on Pyomyositis Patient Handouts on Pyomyositis Directions to Hospitals Treating Pyomyositis Risk calculators and risk factors for Pyomyositis
|
Healthcare Provider Resources |
Causes & Risk Factors for Pyomyositis |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
Synonyms and keywords: Tropical pyomyositis; Myositis tropicans; Bungpagga; Lambo lambo; Tropical skeletal muscle abscess; Myositis purulenta tropica; Bacterial myositis; Suppurative myositis; Epidemic abscess
Overview
Pyomyositis, also known as tropical pyomyositis or myositis tropicans is an acute, primary deep bacterial infection of the skeletal muscles which results in a pus-filled abscess. Pyomyositis is more common in tropical areas but can also occur in the temperate zones. Pyomyositis is most often caused by the bacterium Staphylococcus aureus. In tropical regions, the infection often follows minor trauma, while in temperate zones the infection typically occurs in people with immune deficiencies. The abscess within the muscle is drained surgically and antibiotics are administered to fully clear the infection. The infection can affect any skeletal muscle, but most often infects the large muscle groups such as the quadriceps or gluteal muscles.[1][2]
Historical Perspective
- Traquair credited Virchow for the earliest mention of pyomyositis, however it was first described by Scriba in 1885 as a disease endemic to tropics. Hence the term tropical myositis.[3]
Classification
Pyomyositis may be classified according to international classification of diseases-10(ICD-10) into
- M60.0 Infectious myositis, Tropical pyomyositis (optionally, B95-B97 to indicate the infectious agent; B95.6 for Staphylococcus aureus)[3][4]
Pathophysiology
Pathogenesis
Gross
Microscopic histopathological analysis
Images
Causes
Pyomyositis is an acute bacterial infection of skeletal muscle. Common causes of pyomyositis include:[3]
Bacteria
Most common cause
- Staphylococcus aureus(90% cases in tropical and 75% cases in temperate regions)
Less common bacteria
- Group A streptococci(1%-5% of cases)
- Group B,C,G streptococci
- Streptococcus pneumoniae
- Escherichia coli
- Pseudomonas mallei
- Pseudomonas pseudomallei
- Pneumococcus
- Neisseria
- Haemophilus
- Aeromonas
- Serratia
- Yersinia
- Klebsiella
Rare bacteria
Differentiating Pyomyositis from Other Diseases
Epidemiology and Demographics
Age
Pyomyositis is mainly a disease of children(2-5 yrs) but infection may occur in any age group.
Tropical countries
Pyomyositis is more common in the tropics, Where it accounts for 4% of all hospital admissions.
Temperate countries
In temperate countries like United states, pyomyositis was a rare condition(accounting for 1 in 3000 pediatric admissions), but has become more common since the appearance of the USA300 strain of MRSA.
Risk Factors
The common risk factors in the development of pyomyositis include:[3]
- Blunt trauma
- Vigorous exercise
- Intravenous drug abuse
- Intramuscular injections
- Nutritional deficiencies
- Immunosupression
- HIV
- Immunosupressive drugs
- Organ transplantation
- Liver cirrhosis
- Renal insufficiency
- Diabetis mellitus
- Viral infections
- Parasitic infections
Screening
Natural History, Complications, and Prognosis
Natural History
Complications
Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
- Pyomyositis[5]
- Preferred regimen (3): Cefazolin 2 g IV q8h (if MSSA)
- Alternate regimen: Vancomycin 1 g IV q12h (if MRSA)
Surgery
Prevention
References
- ↑ Unnikrishnan PN, Perry DC, George H, Bassi R, Bruce CE (2010). "Tropical primary pyomyositis in children of the UK: an emerging medical challenge". Int Orthop. 34 (1): 109–13. doi:10.1007/s00264-009-0765-6. PMC 2899277. PMID 19340425.
- ↑ Chauhan S, Jain S, Varma S, Chauhan SS (2004). "Tropical pyomyositis (myositis tropicans): current perspective". Postgrad Med J. 80 (943): 267–70. PMC 1743005. PMID 15138315.
- ↑ 3.0 3.1 3.2 3.3 , S., et al. "Tropical pyomyositis (myositis tropicans): current perspective." Postgraduate medical journal 80.943 (2004): 267-270.
- ↑ Wikipedia(2016).https://de.wikipedia.org/wiki/Pyomyositis Accessed on August 15,2016
- ↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.